CIK 0001703647
- Non-accelerated filer
- Smaller reporting company
Korro Bio, Inc.
Sign in to watch- Ticker
- KRRO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472324450
- Phone
- +1 617-468-1999
- Business address
- 60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA, 02141
- Former names
- Frequency Therapeutics, Inc.
- Open-market buys, last 90 days
- $884,752
- in 1 filing
- Open-market sales, last 90 days
- $1,763,410
- in 5 filings, $1.8M under 10b5-1 plans
Net −$878,658. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 5 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-15 | Cerio Jeffrey General Counsel | Grant or award | +6,500 | 41,793 | ||
| 2026-06-16 | Cerio Jeffrey General Counsel | Sale | −6,609 | $10.83 | $72K | 35,293 |
| 2026-02-02 | Cerio Jeffrey General Counsel | Grant or award · Stock Option (Right to Buy) | +23,000 | 23,000 | ||
| 2025-12-15 | Cerio Jeffrey General Counsel | Grant or award | +41,902 | 41,902 | ||
| 2025-02-03 | Cerio Jeffrey General Counsel | Grant or award · Stock Option (Right to Buy) | +29,000 | 29,000 | ||
| 2024-09-03 | Cerio Jeffrey General Counsel | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 |
Page 1 of 1 · 6 trades